Work

Phase I study of the combination of everolimus (RAD001) with 5FU/LV in patients with refractory solid malignancies.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.4_suppl.512

Authors: J. M. Davies, A. J. McRee, H. K. Sanoff, T. Triglianos, K. Keller, A. Ivanova, S. A. Bernard, R. M. Goldberg, E. C. Dees, B. H. O'Neil

Institutions: University of North Carolina at Chapel Hill, University of Virginia

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2210726162

Cites:

Cited by: 3

Related to: 10